#USA #Indianapolis #Healthcare Conference #Eli Lilly #Ilya Yuffa

Eli Lilly to Join Citi's 2025 Global Healthcare Conference

Eli Lilly and Company, a leader in the pharmaceutical industry, is poised to participate in the Citi's Global Healthcare Conference scheduled for December 2, 2025. The event will take place at a pivotal moment for the company as it continues to make strides in health innovation and patient care.

During the conference, Ilya Yuffa, the Executive Vice President and President of Lilly USA and Global Customer Capabilities, will engage in a fireside chat at 10:30 a.m. Eastern Time. This session is expected to provide insightful discussions on Lilly's latest efforts in advancing healthcare solutions and innovations that have the potential to transform the lives of millions.

Live Webcast Details

For those interested in tuning in to the chat, Lilly will host a live audio webcast within the "Webcasts and Presentations" section of their investor website, which can be found at investor.lilly.com/webcasts-and-presentations. Following the live session, a recorded version of the presentation will be made available for approximately 90 days, enabling stakeholders and the public to access this valuable information.

Eli Lilly's Mission and Innovations

Eli Lilly has a rich history spanning nearly 150 years, during which it has been committed to turning scientific advancements into effective health solutions, thereby improving the quality of life for people across the globe. The company utilizes its expertise in biotechnology, chemistry, and genetics to tackle some of the healthcare sector's most pressing issues.

Lilly’s portfolio of treatments is particularly notable for its innovations in diabetes care, obesity management, neurodegenerative disease therapies, and immune system disorders, as well as breakthroughs in oncology. By redefining treatment protocols and enhancing disease management, Lilly aims to address the challenges posed by these significant health issues.

Commitment to Accessibility and Diversity

Being a responsible leader in the field, Lilly emphasizes the importance of diversity in its clinical trials and works diligently to ensure that its medicines remain accessible and affordable to those in need. Their initiatives reflect a broader commitment to inclusivity and the recognition of diverse populations in the development of new health solutions, which ultimately leads to better outcomes for a wider range of patients.

As Lilly gears up for the up-and-coming healthcare conference, industry experts and advocates alike will be watching closely to see how the company's strategies evolve. The discussions led by Ilya Yuffa are anticipated to not only highlight Lilly’s ongoing projects but also set a tone for future industry benchmarks in patient-centric healthcare advancements.

For further details about Lilly’s participation, recent innovations, and the live webcast, stakeholders and the general public can visit Lilly's official website or follow them on their social media platforms including Facebook, Instagram, and LinkedIn to stay updated with their initiatives and developments.

Eli Lilly continues its mission to pioneer healthcare innovations that contribute effectively to the well-being of global communities, making this upcoming conference a notable opportunity for learning and growth in the healthcare sector.